Trademark Overview
On Friday, June 30, 2000, a trademark application was filed for PREDIXIAN with the United States Patent and Trademark Office. The USPTO has given the PREDIXIAN trademark a serial number of 76081563. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, August 7, 2001. This trademark is owned by Texas Biotechnology Corporation. The PREDIXIAN trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical products for use as an anticoagulant and for the treatment of heparin-induced thrombocytopenia with or without thrombosis, acute coronary syndromes, ischemic stroke, percutaneous coronary interventions, venous thrombosis, arterial thrombosis, coagulopathies, pulmonary embolism, peripheral embolism and hemodialysis